These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3170995)

  • 1. The effect of immunotherapy on bronchial hyperresponsiveness and eosinophil cationic protein in pollen-allergic patients.
    Rak S; Löwhagen O; Venge P
    J Allergy Clin Immunol; 1988 Sep; 82(3 Pt 1):470-80. PubMed ID: 3170995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Basophil histamine release, IgE, eosinophil counts, ECP, and EPX are related to the severity of symptoms in seasonal allergic rhinitis.
    Winther L; Moseholm L; Reimert CM; Stahl Skov P; Kaergaard Poulsen L
    Allergy; 1999 May; 54(5):436-45. PubMed ID: 10380774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of nasal triamcinolone acetonide on seasonal variations of bronchial hyperresponsiveness and bronchial inflammation in nonasthmatic children with seasonal allergic rhinitis.
    Orhan F; Sekerel BE; Adalioglu G; Pinar M; Tuncer A
    Ann Allergy Asthma Immunol; 2004 Apr; 92(4):438-45. PubMed ID: 15104196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of serum levels of eosinophil cationic protein to monitor patients with seasonal respiratory allergy induced by Parietaria pollen (treated and untreated with specific immunotherapy).
    D'Amato G; Liccardi G; Russo M; Saggese M; D'Amato M
    Allergy; 1996 Apr; 51(4):245-50. PubMed ID: 8792921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asthma, bronchial hyperreactivity and mediator release in children with birch pollinosis. ECP and EPX levels are not related to bronchial hyperreactivity.
    Ferdousi HA; Dreborg S
    Clin Exp Allergy; 1997 May; 27(5):530-9. PubMed ID: 9179427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Demonstration of bronchial eosinophil activity in seasonal allergic rhinitis by induced plasma exudation combined with induced sputum.
    Greiff L; Andersson M; Svensson C; Linden M; Wollmer P; Persson CG
    Thorax; 1999 Jan; 54(1):33-6. PubMed ID: 10343628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blinded, comparative study of the effects of short preseason specific immunotherapy and topical steroids in patients with allergic rhinoconjunctivitis and asthma.
    Rak S; Heinrich C; Jacobsen L; Scheynius A; Venge P
    J Allergy Clin Immunol; 2001 Dec; 108(6):921-8. PubMed ID: 11742269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Priming of eosinophil adhesion in patients with birch pollen allergy during pollen season: effect of immunotherapy.
    Håkansson L; Heinrich C; Rak S; Venge P
    J Allergy Clin Immunol; 1997 Apr; 99(4):551-62. PubMed ID: 9111502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum levels of eosinophil cationic protein and eosinophil protein x in pollen atopic patients with stable asthma and its relation with bronchial hyperresponsiveness.
    Chivato T; Martínez D; Blasco R; Melgarejo M; Gómez de Terreros FJ; Laguna R
    Allergol Immunopathol (Madr); 1996; 24(6):243-7. PubMed ID: 9010559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy abrogates the generation of eosinophil and neutrophil chemotactic activity during pollen season.
    Rak S; Håkanson L; Venge P
    J Allergy Clin Immunol; 1990 Nov; 86(5):706-13. PubMed ID: 2229837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of immunotherapy on the inflammation in pollen asthma.
    Rak S
    Allergy; 1993; 48(17 Suppl):125-8; discussion 143-4. PubMed ID: 8109703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum eosinophil cationic protein (ECP) as a marker of disease activity and treatment efficacy in seasonal asthma.
    Vatrella A; Ponticiello A; Parrella R; Romano L; Zofra S; DiLeva A; Bariffi F
    Allergy; 1996 Aug; 51(8):547-55. PubMed ID: 8874658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of soluble CD23 in patients with asthma or rhinitis monosensitive to Parietaria. Its relation to total serum IgE levels and eosinophil cationic protein during and out of the pollen season.
    Di Lorenzo G; Drago A; Pellitteri ME; Candore G; Colombo A; Potestio M; Di Salvo A; Mansueto S; Caruso C
    Allergy Asthma Proc; 1999; 20(2):119-25. PubMed ID: 10209690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tree-pollen allergy is efficiently treated by short-term immunotherapy (STI) with seven preseasonal injections of molecular standardized allergens.
    Balda BR; Wolf H; Baumgarten C; Klimek L; Rasp G; Kunkel G; Müller S; Mann W; Hauswald B; Heppt W; Przybilla B; Amon U; Bischoff R; Becher G; Hummel S; Frosch PJ; Rustemeyer T; Jäger L; Brehler R; Luger T; Schnitker J
    Allergy; 1998 Aug; 53(8):740-8. PubMed ID: 9722222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of immunotherapy on eosinophil accumulation and production of eosinophil chemotactic activity in the lung of subjects with asthma during natural pollen exposure.
    Rak S; Björnson A; Håkanson L; Sörenson S; Venge P
    J Allergy Clin Immunol; 1991 Dec; 88(6):878-88. PubMed ID: 1744358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Once daily intranasal fluticasone propionate (200 micrograms) reduces nasal symptoms and inflammation but also attenuates the increase in bronchial responsiveness during the pollen season in allergic rhinitis.
    Foresi A; Pelucchi A; Gherson G; Mastropasqua B; Chiapparino A; Testi R
    J Allergy Clin Immunol; 1996 Aug; 98(2):274-82. PubMed ID: 8757203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of anti-immunoglobulin E on nasal inflammation in patients with seasonal allergic rhinoconjunctivitis.
    Bez C; Schubert R; Kopp M; Ersfeld Y; Rosewich M; Kuehr J; Kamin W; Berg AV; Wahu U; Zielen S
    Clin Exp Allergy; 2004 Jul; 34(7):1079-85. PubMed ID: 15248853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bronchial hyperresponsiveness and airway inflammation markers in nonasthmatics with allergic rhinitis.
    Polosa R; Ciamarra I; Mangano G; Prosperini G; Pistorio MP; Vancheri C; Crimi N
    Eur Respir J; 2000 Jan; 15(1):30-5. PubMed ID: 10678617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis.
    Keskin O; Tuncer A; Adalioglu G; Sekerel BE; Saçkesen C; Kalayci O
    Pediatr Allergy Immunol; 2006 Sep; 17(6):396-407. PubMed ID: 16925684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Degranulation of eosinophils from pollen-atopic patients with asthma is increased during pollen season.
    Carlson M; Håkansson L; Kämpe M; Stålenheim G; Peterson C; Venge P
    J Allergy Clin Immunol; 1992 Jan; 89(1 Pt 1):131-9. PubMed ID: 1309840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.